<SEC-DOCUMENT>0001580642-25-000420.txt : 20250124
<SEC-HEADER>0001580642-25-000420.hdr.sgml : 20250124
<ACCEPTANCE-DATETIME>20250124133433
ACCESSION NUMBER:		0001580642-25-000420
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250124

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEMAITRE VASCULAR INC
		CENTRAL INDEX KEY:			0001158895
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-82487
		FILM NUMBER:		25553339

	BUSINESS ADDRESS:	
		STREET 1:		63 SECOND AVENUE
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803
		BUSINESS PHONE:		781-221-2266

	MAIL ADDRESS:	
		STREET 1:		63 SECOND AVENUE
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Copeland Capital Management, LLC
		CENTRAL INDEX KEY:			0001541743
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		161 WASHINGTON STREET
		STREET 2:		SUITE 1325
		CITY:			CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428
		BUSINESS PHONE:		484-530-4300

	MAIL ADDRESS:	
		STREET 1:		161 WASHINGTON STREET
		STREET 2:		SUITE 1325
		CITY:			CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Copeland Capital Management, LLC -->
          <cik>0001541743</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001158895</issuerCik>
        <issuerName>LEMAITRE VASCULAR INC</issuerName>
        <issuerCusip>525558201</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>63 Second Avenue</com:street1>
          <com:city>Burlington</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>01803</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Copeland Capital Management</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>803212.00</soleVotingPower>
        <sharedVotingPower>185768.00</sharedVotingPower>
        <soleDispositivePower>803212.00</soleDispositivePower>
        <sharedDispositivePower>185768.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>988980.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.21</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>LEMAITRE VASCULAR INC</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>63 Second Avenue Burlington, Massachusetts 01803</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Sofia A. Rosala</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>161 Washington St, Suite 1325, Conshohocken, PA 19428</principalBusinessOfficeOrResidenceAddress>
        <citizenship>U.S.A</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>5.21%</amountBeneficiallyOwned>
        <classPercent>5.21%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>803,212</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>185,768</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>803,212</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>185,678</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Sofia A. Rosala is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Copeland Capital Management</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Sofia A. Rosala</signature>
        <title>General Counsel and CCO</title>
        <date>01/24/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
